Source: CURATED

Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs6983267
rs6983267
POU5F1B ; CASC8 ; PCAT1 ; CCAT2
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate 		G 0.800 GeneticVariation GWASDB Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies. 24753544

2014
dbSNP: rs6983267
rs6983267
POU5F1B ; CASC8 ; PCAT1 ; CCAT2
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate 		0.800 GeneticVariation GWASDB Genome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population. 23555315

2013
dbSNP: rs6983267
rs6983267
POU5F1B ; CASC8 ; PCAT1 ; CCAT2
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate 		G 0.800 GeneticVariation GWASDB Multiple loci identified in a genome-wide association study of prostate cancer. 18264096

2008
dbSNP: rs6983267
rs6983267
POU5F1B ; CASC8 ; PCAT1 ; CCAT2
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate 		G 0.800 GeneticVariation GWASDB Multiple newly identified loci associated with prostate cancer susceptibility. 18264097

2008
dbSNP: rs6983267
rs6983267
POU5F1B ; CASC8 ; PCAT1 ; CCAT2
CUI: C0376358
Disease: Malignant neoplasm of prostate
Malignant neoplasm of prostate 		G 0.800 GeneticVariation GWASDB A combined analysis with four additional studies (total: 4,296 cases and 4,299 controls) confirms association with prostate cancer for rs6983267 in the centromeric locus (P = 9.42 x 10(-13); heterozygote odds ratio (OR): 1.26, 95% confidence interval (c.i.): 1.13-1.41; homozygote OR: 1.58, 95% c.i.: 1.40-1.78). 17401363

2007